- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05964400
duoABLE for People With Stroke and Their Caregivers
October 17, 2024 updated by: University of Minnesota
duoABLE for People With Stroke and Their Caregivers (Feasibility)
The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities.
Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- School of Kinesiology, University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria (Stroke Participants):
- Stroke diagnosed more than 6 months ago
- Are 18 years of age or older
- Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week
- Reside in a community-based setting
- Are mobile within their home, with or without an assistive device and without physical assistance
- Are able to identify an eligible caregiver who will engage in assessments and intervention.
Inclusion Criteria (Caregiver Participants):
- Are 18 years of age or older
- Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week
- Reside in a community-based setting
- Are mobile within their home, with or without an assistive device and without physical assistance
Exclusion Criteria (Stroke Participants):
- Severe aphasia
- Are currently receiving chemotherapy or radiation treatments for cancer
- Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)
- Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months
- Have a history of skin sensitivity related to adhesives
- Are pregnant or expecting to become pregnant in the next 2 months
- Reside in an institutional setting
- Are currently incarcerated
Exclusion Criteria (Caregiver Participants):
- Have a history of skin sensitivity related to adhesives
- Are currently receiving chemotherapy or radiation treatments for cancer
- Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)
- Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months
- Are pregnant or expecting to become pregnant in the next 2 months
- Reside in an institutional setting
- Are currently incarcerated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: duoABLE
Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels
|
Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant satisfaction
Time Frame: Score at week 8
|
Measured using the Client Satisfaction Questionnaire-8 (CSQ-8)
|
Score at week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in activity restrictions
Time Frame: Baseline to 8 weeks
|
Proportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3
|
Baseline to 8 weeks
|
|
Change in sedentary minutes per day
Time Frame: Baseline to 8 weeks
|
Minutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8.
|
Baseline to 8 weeks
|
|
Change in daily step count
Time Frame: Baseline to 8 weeks
|
Count of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8.
|
Baseline to 8 weeks
|
|
Change in Health-related quality of life
Time Frame: Baseline to 8 weeks
|
Change in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8
|
Baseline to 8 weeks
|
|
Adverse event count
Time Frame: Count of adverse events at week 8
|
Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks
|
Count of adverse events at week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Emily A Kringle, PhD, OTR/L, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2023
Primary Completion (Actual)
August 24, 2024
Study Completion (Actual)
August 24, 2024
Study Registration Dates
First Submitted
July 18, 2023
First Submitted That Met QC Criteria
July 18, 2023
First Posted (Actual)
July 27, 2023
Study Record Updates
Last Update Posted (Actual)
October 21, 2024
Last Update Submitted That Met QC Criteria
October 17, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- duoABLE
- AOTFIRG23KRINGLE (Other Grant/Funding Number: American Occupational Therapy Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
There are no current plans to share data with other investigators.
Upon the completion of the study, a de-identified dataset that includes questionnaire data, raw and processed activPAL data, and transcribed interview data will be created and stored in the DWELL Laboratory at the University of Minnesota.
The PI will consider individual requests for data sharing and provide only the necessary de-identified data upon reasonable request, under a University of Minnesota data use agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly